Login to Your Account



Neuro3d's Third Round: EUR31.5M For Development Of Lead Drugs

By James Etheridge


Wednesday, January 5, 2005
PARIS - Neuro3d closed a third round of financing in which it raised €31.5 million (US$41.6 million) from eight European venture capital funds. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription